Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 1/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.47 |
| ▸ | PPARG | P37231 | 7/20 | 0.47 |
| ▸ | PPARD | Q03181 | 7/20 | 0.47 |
| ▸ | PPARA | Q07869 | 7/20 | 0.47 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.47 |
| ▸ | TSHR | P16473 | 5/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | TLR2 | O60603 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | FABP4 | P15090 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.47 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | ESR1 | P03372 | 1/20 | 0.47 |
| ▸ | PDE4A | P27815 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL158234 | 0.97 | AKR1B1 (0.53) | AKR1B1GPR84PPARGPPARDPPARA | |
| Adipic Acid SCHEMBL22444199 | 0.97 | AKR1B1 (0.53) | AKR1B1GPR84PPARGPPARDPPARA | |
| SCHEMBL30807881 | 0.95 | GPR84 (0.55) | AKR1B1GPR84PPARGPPARDPPARA | |
| SCHEMBL5701165 | 0.95 | GPR84 (0.55) | AKR1B1GPR84PPARGPPARDPPARA | |
| SCHEMBL28147208 | 0.95 | GPR84 (0.55) | AKR1B1GPR84PPARGPPARDPPARA | |
| SCHEMBL6397467 | 0.95 | GPR84 (0.55) | AKR1B1GPR84PPARGPPARDPPARA | |
| SCHEMBL19471289 | 0.95 | GPR84 (0.55) | AKR1B1GPR84PPARGPPARDPPARA | |
| SCHEMBL182514 | 0.95 | GPR84 (0.55) | AKR1B1GPR84PPARGPPARDPPARA | |
| SCHEMBL5864687 | 0.93 | DGKA (0.42) | TSHRALDH1A1MAPTPAMLMNA | |
| SCHEMBL27867163 | 0.92 | AKR1B1 (0.50) | AKR1B1GPR84PPARGPPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260069734-A1 | FRESHENING COMPOSITIONS COMPRISING CONTROLLED RELEASE MODULATORS | ARYLESSENCE INC (US) | 2026-03-12 | — | — | US | disclosed |
| US-10253238-B2 | Anti-accretion additives for wellbore fluids and methods of use thereof | M-I L.L.C. (US) | 2019-04-09 | — | — | US | disclosed |
| US-20170137692-A1 | ANTI-ACCRETION ADDITIVES FOR WELLBORE FLUIDS AND METHODS OF USE THEREOF | M-I L.L.C. (US) | 2017-05-18 | — | — | US | disclosed |
| US-7060301-B2 | In situ mono-or diester dicarboxylate compositions | ECOLAB INC. (US) | 2006-06-13 | — | — | US | disclosed |
| US-6627593-B2 | A high concentration monoester peroxy dicarboxylic acid composition comprising: 6 wt-% monoester peroxy dicarboxylic acid; about 10 wt-% diester dicarboxylate; anionic surfactant, amine oxide surfactant, or a mixture thereof; hydrogen | ECOLAB INC. | 2003-09-30 | — | — | US | disclosed |
| US-20030087786-A1 | High concentration monoester peroxy dicarboxylic acid compositions, use solutions, and methods employing them | ECOLAB USA INC. | 2003-05-08 | — | — | US | disclosed |
| US-20030021853-A1 | In situ mono-or diester dicarboxylate compositions | ECOLAB USA INC. | 2003-01-30 | — | — | US | disclosed |
| WO-2003005817-A2 | HIGH CONCENTRATION MONOESTER PEROXY DICARBOXYLIC ACID COMPOSITIONS, USE SOLUTIONS, AND METHODS EMPLOYING THEM | ECOLAB INC. (US) | 2003-01-23 | — | — | WO | disclosed |
| WO-2003005818-A1 | IN SITUMONO-OR DIESTER DICARBOXYLATE COMPOSITIONS | ECOLAB INC. (US) | 2003-01-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030021853-A1 | In situ mono-or diester dicarboxylate compositions | DDC, HCAR3, ACMSD | AKR1B1 848/4885GPR84 643/4885PPARG 818/4885 |
| US-20260069734-A1 | FRESHENING COMPOSITIONS COMPRISING CONTROLLED RELEASE MODULATORS | FFAR1, FFAR2, FFAR3 | AKR1B1 549/4885GPR84 646/4885PPARG 9/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.